Spatiotemporal regulation of ERK2 by dual specificity phosphatases

Christopher J Caunt1, Stephen P Armstrong, Caroline A Rivers

  • 1Laboratory for Integrated Neuroscience and Endocrinology, Department of Clinical Sciences at South Bristol, University of Bristol, Whitson Street, Bristol BS1 3NY, United Kingdom.

Insights

Dual specificity phosphatases (DUSPs) significantly regulate extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathways. This study reveals numerous DUSPs as key modulators of ERK1/2 activity and localization, suggesting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling is crucial for cellular regulation but its kinetics and localization are stimulus-dependent.
  • Dual specificity phosphatases (DUSPs), including MAPK phosphatases (MKPs) and atypical DUSPs, inactivate ERKs by dephosphorylation and scaffolding.
  • Understanding DUSP roles in modulating ERK1/2 signaling is vital for deciphering cell physiology and developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of DUSPs on the kinetics and compartmentalization of ERK1/2 signaling in response to different stimuli.
  • To identify specific DUSP subtypes that act as positive or negative regulators of ERK1/2 pathways.
  • To explore potential cross-talk between MAPK pathways mediated by DUSPs and assess DUSPs as therapeutic targets.

Main Methods:

  • Utilized a cell imaging model with ERK2-GFP reporters (wild-type and D319N mutant) following knockdown of endogenous ERKs.
  • Applied transient (epidermal growth factor) and sustained (phorbol 12,13-dibutyrate) ERK2 activators.
  • Conducted a short inhibitory RNA screen of 16 DUSPs and analyzed mRNA levels of DUSPs; used kinase inhibitors for pathway analysis.

Main Results:

  • A D319N mutation, impairing DUSP binding, increased ERK2 activity and reduced nuclear accumulation for both stimuli.
  • Stimuli elevated mRNA levels for eight DUSPs, and a screen identified 12 of 16 DUSPs influencing ERK2 responses.
  • JNK/p38 MKPs and nuclear inducible MKPs were identified as positive and negative ERK2 regulators, respectively; DUSP effects involved MAPK pathway cross-talk.

Conclusions:

  • A substantial number of DUSPs actively modulate ERK1/2 signaling dynamics and localization.
  • Specific DUSP subtypes play distinct roles, acting as either positive or negative regulators of ERK1/2 pathways.
  • DUSPs represent promising therapeutic targets due to their significant influence on ERK1/2 signaling and potential for cross-talk modulation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...